[Form 4] Vita Coco Company, Inc. Insider Trading Activity
Vita Coco Company director Liran Ira reported two securities dispositions on 09/12/2025. The filings show sales of 20,000 and 40,000 shares of common stock executed under a Rule 10b5-1 trading plan, with weighted-average prices reported near $40.00 per share. After the transactions the reporting person is shown as beneficially owning 598,341 shares directly and 742,579 shares indirectly (held by the Ira Liran 2012 Family Trust). The Form 4 was signed by an attorney-in-fact on 09/16/2025.
Il direttore della Vita Coco Company, Liran Ira, ha riportato due disposizioni di titoli il 09/12/2025. Le comunicazioni mostrano vendite di 20,000 e 40,000 azioni ordinarie eseguite nell'ambito di un piano di negoziazione Rule 10b5-1, con prezzi medi ponderati riportati vicino a $40.00 per azione. Dopo le transazioni la persona che segnala è indicata come titolare effettivo di 598,341 azioni direttamente e 742,579 azioni indirettamente ( detenute dal Ira Liran 2012 Family Trust ). Il Modulo 4 è stato firmato da un procuratore il 09/16/2025.
El director de Vita Coco Company, Liran Ira, informó de dos disposiciones de valores el 09/12/2025. Las comunicaciones muestran ventas de 20,000 y 40,000 acciones ordinarias ejecutadas bajo un plan de negociación Rule 10b5-1, con precios medios ponderados reportados alrededor de $40.00 por acción. Después de las transacciones, la persona informante figura como titular beneficioso de 598,341 acciones directamente y 742,579 acciones indirectamente (poseídas por el Ira Liran 2012 Family Trust). El Formulario 4 fue firmado por un apoderado el 09/16/2025.
Vita Coco Company의 이사인 Liran Ira가 2025년 9월 12일 두 건의 증권 처분을 보고했습니다. 공시에는 Rule 10b5-1 거래 계획에 따라 20,000주와 40,000주의 보통주 매도가 보고되었으며, 주당 가중평균가가 $40.00에 근접하게 보고되었습니다. 거래 후 보고자는 직접 보유한 598,341주와 간접적으로 보유한 742,579주( Ira Liran 2012 Family Trust 소유)로 나타납니다. Form 4는 2025년 9월 16일에 대리인에 의해 서명되었습니다.
Le directeur de Vita Coco Company, Liran Ira, a signalé deux cessions de titres le 09/12/2025. Les dépôts indiquent des ventes de 20,000 et 40,000 actions ordinaires réalisées dans le cadre d'un plan de négociation Rule 10b5-1, avec des prix moyens pondérés indiqués autour de $40.00 par action. Après les transactions, la personne déclarant est indiquée comme détenant directement 598,341 actions et indirectement 742,579 actions (détenues par le Ira Liran 2012 Family Trust). Le Formulaire 4 a été signé par un mandataire le 09/16/2025.
Der Direktor von Vita Coco Company, Liran Ira, meldete am 12.09.2025 zwei Wertpapierabgaben. Die Einreichungen zeigen Verkäufe von 20.000 und 40.000 Stammaktien, die im Rahmen eines Rule-10b5-1-Handelsplans durchgeführt wurden, mit gewichteten Durchschnittspreisen um $40,00 pro Aktie. Nach den Transaktionen wird der meldepflichtige Person als direkt 598.341 und indirekt 742.579 Aktien besitzend dargestellt (im Ira Liran 2012 Family Trust gehalten). Das Formblatt 4 wurde am 16.09.2025 von einem Bevollmächtigten unterzeichnet.
أفاد مدير شركة فيتا كوكو، ليران إيرا، بوجود تصرّفين على الأوراق المالية في 09/12/2025. تُظهِر الإجراءات وجود مبيعات لـ 20,000 و 40,000 سهماً من الأسهم العادية تم تنفيذها ضمن خطة تداول Rule 10b5-1، مع الإبلاغ عن أسعار متوسطة مرجحة تقارب $40.00 للسهم الواحد. بعد الصفقتين يظهر الشخص المبلّغ عنه وهو يمتلك بشكل مباشر 598,341 سهماً وبشكل غير مباشر 742,579 سهماً (مع وجودها لدى Ira Liran 2012 Family Trust). وقد تم توقيع النموذج 4 من قبل وكيل نيابة في 09/16/2025.
Vita Coco Company 的董事 Liran Ira 于 2025-09-12 披露了两笔证券处置。申报显示在 Rule 10b5-1 交易计划下，出售了 20,000 股和 40,000 股普通股，加权平均价格报告为每股约 $40.00。交易完成后，申报人直接持有 598,341 股，间接持有 742,579 股（由 Ira Liran 2012 Family Trust 持有）。Form 4 于 2025-09-16 由代理人签署。
- Sales executed under a Rule 10b5-1 trading plan, indicating pre-planned dispositions
- Disclosure includes explanatory footnotes with weighted-average price ranges for transparency
- Form filed and signed by attorney-in-fact, indicating formal submission
- Dispositions of 60,000 shares (20,000 and 40,000) were reported, which reduce the insider's liquid holdings
- Sales occurred at prices around $40 per share, representing notable insider liquidity on that date
- Some holdings are indirect (742,579 shares held by the Ira Liran 2012 Family Trust), which can complicate direct control assessment
Insights
TL;DR: Insider sold 60,000 shares via a Rule 10b5-1 plan; transactions are pre-planned and disclosed.
The Form 4 reports two dispositions totaling 60,000 shares on 09/12/2025 executed pursuant to a Rule 10b5-1 trading plan, with weighted-average prices reported around $40 per share. Such 10b5-1 sales indicate pre-scheduled liquidity rather than ad-hoc insider trading. The filing also discloses continued substantial direct and indirect holdings: 598,341 direct and 742,579 indirect shares (the latter held in the Ira Liran 2012 Family Trust). From an investor disclosure standpoint, the form is consistent with routine insider liquidity and proper SEC reporting.
TL;DR: Disclosure appears compliant; sales were covered by a Rule 10b5-1 plan and the Form 4 is executed by attorney-in-fact.
The report explicitly states the sales were effected under a Rule 10b5-1 plan and includes explanatory footnotes describing weighted-average price ranges. The form indicates the reporting person is a company director and the signature was provided by an attorney-in-fact on 09/16/2025. These elements suggest adherence to procedural disclosure requirements. The filing does not include any information about intent or rationale beyond the 10b5-1 designation.
Il direttore della Vita Coco Company, Liran Ira, ha riportato due disposizioni di titoli il 09/12/2025. Le comunicazioni mostrano vendite di 20,000 e 40,000 azioni ordinarie eseguite nell'ambito di un piano di negoziazione Rule 10b5-1, con prezzi medi ponderati riportati vicino a $40.00 per azione. Dopo le transazioni la persona che segnala è indicata come titolare effettivo di 598,341 azioni direttamente e 742,579 azioni indirettamente ( detenute dal Ira Liran 2012 Family Trust ). Il Modulo 4 è stato firmato da un procuratore il 09/16/2025.
El director de Vita Coco Company, Liran Ira, informó de dos disposiciones de valores el 09/12/2025. Las comunicaciones muestran ventas de 20,000 y 40,000 acciones ordinarias ejecutadas bajo un plan de negociación Rule 10b5-1, con precios medios ponderados reportados alrededor de $40.00 por acción. Después de las transacciones, la persona informante figura como titular beneficioso de 598,341 acciones directamente y 742,579 acciones indirectamente (poseídas por el Ira Liran 2012 Family Trust). El Formulario 4 fue firmado por un apoderado el 09/16/2025.
Vita Coco Company의 이사인 Liran Ira가 2025년 9월 12일 두 건의 증권 처분을 보고했습니다. 공시에는 Rule 10b5-1 거래 계획에 따라 20,000주와 40,000주의 보통주 매도가 보고되었으며, 주당 가중평균가가 $40.00에 근접하게 보고되었습니다. 거래 후 보고자는 직접 보유한 598,341주와 간접적으로 보유한 742,579주( Ira Liran 2012 Family Trust 소유)로 나타납니다. Form 4는 2025년 9월 16일에 대리인에 의해 서명되었습니다.
Le directeur de Vita Coco Company, Liran Ira, a signalé deux cessions de titres le 09/12/2025. Les dépôts indiquent des ventes de 20,000 et 40,000 actions ordinaires réalisées dans le cadre d'un plan de négociation Rule 10b5-1, avec des prix moyens pondérés indiqués autour de $40.00 par action. Après les transactions, la personne déclarant est indiquée comme détenant directement 598,341 actions et indirectement 742,579 actions (détenues par le Ira Liran 2012 Family Trust). Le Formulaire 4 a été signé par un mandataire le 09/16/2025.
Der Direktor von Vita Coco Company, Liran Ira, meldete am 12.09.2025 zwei Wertpapierabgaben. Die Einreichungen zeigen Verkäufe von 20.000 und 40.000 Stammaktien, die im Rahmen eines Rule-10b5-1-Handelsplans durchgeführt wurden, mit gewichteten Durchschnittspreisen um $40,00 pro Aktie. Nach den Transaktionen wird der meldepflichtige Person als direkt 598.341 und indirekt 742.579 Aktien besitzend dargestellt (im Ira Liran 2012 Family Trust gehalten). Das Formblatt 4 wurde am 16.09.2025 von einem Bevollmächtigten unterzeichnet.
FAQ
What transactions did Liran Ira report on Form 4 for COCO?
At what prices were the COCO shares sold according to the Form 4?
How many COCO shares does the reporting person beneficially own after the transactions?
Were the sales part of a trading plan or ad-hoc trades?
Who signed the Form 4 and when was it dated?
What entity holds the indirect shares reported on the Form 4?
